BUY | SELL | ||
---|---|---|---|
QTY | PRICE | PRICE | QTY |
161 | 1188.95 | 1189.65 | 1 |
5 | 1188.90 | 1189.70 | 29 |
14 | 1188.85 | 1189.75 | 38 |
31 | 1188.70 | 1189.80 | 4 |
38 | 1188.65 | 1189.85 | 10 |
53765 | Total | Total | 61694 |
As on 20 Nov, 2023 | 10:42
BUY | SELL | ||
---|---|---|---|
QTY | PRICE | PRICE | QTY |
161 | 1188.95 | 1189.65 | 1 |
5 | 1188.90 | 1189.70 | 29 |
14 | 1188.85 | 1189.75 | 38 |
31 | 1188.70 | 1189.80 | 4 |
38 | 1188.65 | 1189.85 | 10 |
53765 | Total | Total | 61694 |
As on --
(OI , PRICE )
As on --
Stock with consistent financial performance, quality management, and strong
Open | 1,196.00 |
Previous Close | 1,194.60 |
Volume | 195,010.00 |
Value (Lacs) | 2,330.66 |
VWAP | 1,192.71 |
Beta |
High | 1,198.25 |
Low | 1,188.15 |
UC Limit | 1,314.05 |
LC Limit | 1,075.15 |
52 Week High | 1,198.40 |
52 Week Low | 922.45 |
TTM EPS See historical trend | 35.63 (+108.27% YoY) |
TTM PE See historical trend | 33.54 (Average PE) |
P/B See historical trend | 5.13 (High P/B) |
Face Value | 1.00 |
Mkt Cap (Rs. Cr.) | 286,757 |
Dividend Yield | 0.96 |
20D Avg Volume | 1,884,936 |
20D Avg Delivery(%) | -- |
Sector PE | 45.96 |
Book Value Per Share | 233.38 |
*Delayed by 20 seconds.
Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
---|---|---|---|---|---|---|---|
Classic | - - | - - | - - | - - | - - | - - | - - |
Fibonacci | - - | - - | - - | - - | - - | - - | - - |
Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
R1 | - - | Pivot - - |
S1 | - - |
R2 | - - | S2 | - - | |
R3 | - - | S3 | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
Days | |
---|---|
5 | - - |
10 | - - |
20 | - - |
50 | - - |
100 | - - |
200 | - - |
Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
---|---|---|---|---|---|---|---|
Classic | - - | - - | - - | - - | - - | - - | - - |
Fibonacci | - - | - - | - - | - - | - - | - - | - - |
Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
R1 | - - | Pivot - - |
S1 | - - |
R2 | - - | S2 | - - | |
R3 | - - | S3 | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
Days |
---|
Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
---|---|---|---|---|---|---|---|
Classic | - - | - - | - - | - - | - - | - - | - - |
Fibonacci | - - | - - | - - | - - | - - | - - | - - |
Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
R1 | - - | Pivot - - |
S1 | - - |
R2 | - - | S2 | - - | |
R3 | - - | S3 | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
Days |
---|
1 Week | --% | |
1 Month | --% | |
3 Months | --% | |
YTD | --% | |
1 Year | --% | |
3 Years | --% |
Sun Pharma: Premium valuation caps upside Nov 02 2023 12:40 PM
Sun Pharma Consolidated September 2023 Net Sales at Rs 12,192.41 crore, up 11.32% Y-o-Y Nov 02 2023 11:38 AM
Sun Pharma Standalone September 2023 Net Sales at Rs 5,096.21 crore, down 3.58% Y-o-Y Nov 02 2023 10:53 AM
Sun Pharma's healthy Q2, stellar specialty sales impresses brokerages, triggers hikes in target prices Nov 02 2023 09:26 AM
Qty 1404266 | Price 1013.55 | % Traded 0.06 |
Qty 1404266 | Price 1013.55 | % Traded 0.06 |
Qty 1404266 | Price 1051.95 | % Traded 0.06 |
Qty 1404266 | Price 1051.95 | % Traded 0.06 |
Qty 755497 | Price 987 | % Traded 0.03 |
Qty 755497 | Price 987 | % Traded 0.03 |
Qty 1187253 | Price 976.3 | % Traded 0.05 |
Qty 1187253 | Price 976.3 | % Traded 0.05 |
*Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.
Qty 15858723 | Price 816.69 | % Traded 0.66 |
Qty 15858723 | Price 816.69 | % Traded 0.66 |
Qty 15850000 | Price 864.01 | % Traded 0.66 |
Qty 15850000 | Price 864.01 | % Traded 0.66 |
Qty 51218896 | Price 930.16 | % Traded 2.13 |
Qty 20161290 | Price 930.16 | % Traded 0.84 |
Qty 12619297 | Price 930.16 | % Traded 0.53 |
Qty 214969058 | Price 931.58 | % Traded 8.96 |
*A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.
Qty 1000000 | Price 937.45 | % Traded 0.04 | Post Tnx Hold. 1.2% |
Qty 2020000 | Price 1117 | % Traded 0.08 | Post Tnx Hold. 1.2% |
Qty 2020000 | Price 1117 | % Traded 0.08 | Post Tnx Hold. 1.2% |
Qty 2420000 | Price 968.55 | % Traded 0.10 | Post Tnx Hold. 1.2% |
Qty 1190000 | Price 968.55 | % Traded 0.05 | Post Tnx Hold. 1.2% |
Qty 119837 | Price 965.25 | % Traded 0.00 | Post Tnx Hold. 40.3% |
*Disclosures under SEBI Prohibition of Insider Trading Regulations, 2015
Qty 48256054 | Price 0 | % Traded 2.01 | Post Tnx Hold. 3.01% |
Qty 0 | Price 0 | % Traded 0.00 | Post Tnx Hold. 0% |
Qty 0 | Price 0 | % Traded 0.00 | Post Tnx Hold. 0% |
Qty 48041542 | Price 0 | % Traded 2.00 | Post Tnx Hold. 5.02% |
Qty 48366975 | Price 0 | % Traded 2.01 | Post Tnx Hold. 7.02% |
*Disclosures under SEBI SAST (Substantial Acquisition of Shares and Takeovers) Regulations, 2011
Date | Agenda |
---|
Ex-Date | Type | Dividend (Rs) |
---|
Announcement Date | Ex-Bonus | Ratio |
---|
Ex-Split | Old FV | New FV |
---|
Ex-Right | Ratio | Premium |
---|
Date | Agenda |
---|
Company Name | Price | % Chg | MCap(Cr) | TTM PE | P/B | ROE(%) | 1 Yr Perform(%) | Net Profit(Rs.) | Net Sales(Rs.) | Debt to Equity |
---|---|---|---|---|---|---|---|---|---|---|
Sun Pharma | 1,189.30 | -0.44 | 285,352.91 | 33.38 | 5.59 | 15.13 | 17.80 | 8,560 | 43,885 | 0.11 |
Cipla | 1,247.60 | -0.14 | 100,721.92 | 29.20 | 4.77 | 11.96 | 13.17 | 2,835 | 22,753 | 0.02 |
Divis Labs | 3,721.40 | 3.35 | 98,791.48 | 74.18 | 8.42 | 14.28 | 13.20 | 1,823 | 7,767 | 0.00 |
Dr Reddys Labs | 5,603.00 | -0.15 | 93,456.28 | 18.36 | 4.85 | 19.35 | 27.08 | 4,470 | 24,669 | 0.05 |
Mankind Pharma | 1,983.50 | 3.30 | 79,456.72 | 56.27 | 10.21 | 16.03 | - | 1,248 | 8,127 | 0.00 |
Your feedback matters! Tell us what we got right and what we didn’t? Click here>